![]() |
市场调查报告书
商品编码
1700083
2032 年初乳市场预测:按来源、性质、形态、分销管道、应用和地区分類的全球分析Colostrum Market Forecasts to 2032 - Global Analysis By Source (Cow, Buffalo, Goat and Sheep), Nature (Conventional and Organic), Form, Distribution Channel, Application and By Geography |
根据 Stratistics MRC 的数据,全球初乳市场预计在 2025 年达到 38 亿美元,到 2032 年将达到 68 亿美元,预测期内的复合年增长率为 8.7%。
哺乳动物出生后立即分泌的第一滴乳汁称为初乳。初乳含有丰富的蛋白质、抗体和其他必需营养素,提供宝宝生长因子和重要的免疫力。这种营养丰富的淡黄色液体有助于消化器官系统的发育并保护宝宝感染疾病。初乳,也被称为“液体黄金”,对于健康免疫系统的早期发育和维持至关重要。
根据国际酪农联合会(IDF)的数据,2019年全球牛奶产量达8.81亿吨,全球有超过60亿人定期食用牛奶和其他乳製品。
提高对健康益处的认识
免疫球蛋白和生长因子等生物活性成分的科学检验不断增加,增强了它们在膳食补充剂、运动营养和婴儿奶粉领域的需求。此外,疫情后预防性医疗保健的趋势也推动其采用。强调其在对抗感染疾病和过敏方面的作用的营销宣传活动进一步推动了增长,尤其是在註重健康的人群中。这种意识正在推动产品创新并扩大机能性食品和膳食补充剂的应用。
限量和季节性供应
初乳的采集需要在产犊后精确计时,因此产量仅限于特定时期。此外,道德的收穫方法和严格的品质标准限制了大规模商业化。酪农集中在北美和欧洲等地区,加剧了供应链瓶颈,并推高了成本。这些因素带来了挑战,尤其是在满足全球对优质和有机乳製品日益增长的需求方面。季节性波动也会导致价格波动,影响价格敏感地区的负担能力和市场渗透率。
对有机和天然产品的需求不断增加
消费者越来越重视洁净标示、非基因改造、无激素的补充剂,这促使初乳生产商采用永续和道德的采购方式。美国农业部有机认证和草饲认证等增加了产品的吸引力。此外,电子商务平台的扩张使得利基市场更容易进入。低温加工方面的创新可以保持生物活性的完整性,这更符合天然产品的趋势,并且可以在机能性食品和婴儿营养等竞争市场中实现差异化。
道德和动物福利问题
关于初乳收集方法的道德问题,特别是早期将牛与牛分开,会带来声誉风险。动物福利法规和活动可能会导致合规要求的增加和生产成本的增加。集约化酪农的负面声誉可能会疏远有道德意识的消费者,并推动对植物来源替代品的需求。此外,在欧洲和北美等地区,监管审查可能会要求采购透明度,要求供应商在盈利和道德规范之间取得平衡。
由于劳动力短缺和物流限制,COVID-19 疫情最初扰乱了初乳供应链。然而,消费者对增强免疫力产品的兴趣日益浓厚,加速了需求,尤其是对膳食补充剂的需求。由于实体零售受到限制,网路销售激增。疫情过后,对预防性医疗保健的持续关注继续推动成长,但通膨压力和原物料成本带来挑战。製造商正在投资数位行销和多样化采购,以减轻未来的干扰。
预计牛市场在预测期内将占最大份额
由于牛具有高免疫球蛋白浓度,广泛用于补充剂、婴儿奶粉和饲料,因此预计牛部分将在预测期内占据最大的市场占有率。它与大规模酪农的兼容性以及检验其健康益处的完善研究确保了其市场领先地位。此外,北美和欧洲强大的乳製品产业确保了稳定的供应。喷雾干燥和粉末状创新进一步增加了从运动营养到医疗治疗等各种应用的可近性。
预计在预测期内,液体部分将以最高的复合年增长率成长。
由于液体饮料的便利性、生物利用度和即饮形式的适用性,预计在预测期内将出现最高的成长率。这一趋势是由对机能饮料和儿科营养产品日益增长的需求所推动的,尤其是在新兴市场。此外,保存技术的进步延长了保质期,同时又不损害营养完整性。由于其与益生菌等其他健康成分的多功能结合,这一领域将在膳食补充剂和临床营养领域呈现指数级增长。
在预测期内,北美预计将占据最大的市场占有率,这得益于其较高的健康意识、强大的研发投入以及完善的膳食补充剂行业。美国拥有密集的酪农网络和对初乳产品的监管支持的优势。对增强免疫力的补充剂和运动营养的需求不断增长,加上优质化趋势,正在支撑市场的成长。製造商和医疗保健提供者之间的策略联盟进一步加强了该地区的地位。
在预测期内,由于中产阶级的扩大、都市化和可支配收入的增加,预计亚太地区将呈现最高的复合年增长率。中国和印度等国家对儿科营养和机能性食品的需求正在蓬勃发展。政府为促进母婴健康而采取的倡议,以及人们对初乳益处的认识不断提高,正在推动初乳的普及。此外,电子商务的扩张和全球品牌进入尚未开发的市场将推动该地区的繁荣,而这得益于疫情后向预防性医疗保健的转变。
According to Stratistics MRC, the Global Colostrum Market is accounted for $3.8 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 8.7% during the forecast period. The first type of milk that mammals generate right after birth is called colostrum. It is abundant in proteins, antibodies, and other necessary nutrients, giving babies growth factors and critical immunity. This yellowish fluid, rich in nutrients, aids in the development of the digestive system and guards against infections. Colostrum, sometimes referred to as "liquid gold," is essential for the development of the immune system early on and for general health.
According to the International Dairy Federation (IDF), global milk production reached 881 million tonnes in 2019, with over 6 billion people worldwide regularly consuming milk or other dairy products.
Growing awareness of health benefits
Increased scientific validation of its bioactive components, such as immunoglobulins and growth factors, has bolstered demand across nutraceuticals, sports nutrition, and infant formula sectors. Additionally, preventive healthcare trends post-pandemic have amplified its adoption. Marketing campaigns highlighting its role in combating infections and allergies further propel growth, particularly among health-conscious demographics. This awareness is driving product innovation and expanding applications in functional foods and dietary supplements.
Limited availability and seasonal supply
Harvesting colostrum requires precise timing post-calving, restricting production to specific periods. Moreover, ethical collection practices and stringent quality standards limit large-scale commercialization. Geographic concentration of dairy farms in regions like North America and Europe exacerbates supply chain bottlenecks, raising costs. These factors challenge manufacturers in meeting rising global demand, particularly for premium and organic variants. Seasonal fluctuations also lead to price volatility, impacting affordability and market penetration in price-sensitive regions.
Growing demand for organic and natural products
Consumers increasingly prioritize clean-label, non-GMO, and hormone-free supplements, driving colostrum producers to adopt sustainable and ethical sourcing practices. Certifications such as USDA Organic and grass-fed claims enhance product appeal. Moreover, the expansion of e-commerce platforms facilitates access to niche markets. Innovations in cold-processing techniques to retain bioactive integrity further align with natural product trends, enabling differentiation in competitive markets like functional foods and infant nutrition.
Ethical and animal welfare concerns
Ethical concerns regarding colostrum harvesting practices, particularly early separation of calves from cows, pose reputational risks. Animal welfare regulations and activism could lead to stricter compliance requirements, increasing production costs. Negative publicity around intensive dairy farming may deter ethically conscious consumers, pushing demand toward plant-based alternatives. Additionally, regulatory scrutiny in regions like Europe and North America could mandate transparency in sourcing, challenging suppliers to balance profitability with ethical practices.
The Covid-19 pandemic initially disrupted colostrum supply chains due to labor shortages and logistics constraints. However, heightened consumer focus on immunity-boosting products accelerated demand, particularly in dietary supplements. Online sales surged as brick-and-mortar retail faced restrictions. Post-pandemic, sustained interest in preventive healthcare continues to drive growth, though inflationary pressures and raw material costs pose challenges. Manufacturers are investing in digital marketing and diversified sourcing to mitigate future disruptions
The cow segment is expected to be the largest during the forecast period
The cow segment is expected to account for the largest market share during the forecast period due to bovine colostrum's superior immunoglobulin concentration and widespread use in supplements, infant formula, and animal feed. Its compatibility with large-scale dairy farming and established research validating health benefits solidify its market leadership. Additionally, North America and Europe's robust dairy industries ensure consistent supply. Innovations in spray-dried and powdered forms further enhance accessibility, catering to diverse applications from sports nutrition to medical therapies.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate driven by its convenience, bioavailability, and suitability for ready-to-drink formats. Rising demand for functional beverages and pediatric nutrition products, especially in emerging markets, fuels this trend. Moreover, advancements in preservation technologies extend shelf life without compromising nutrient integrity. The segment's versatility in combining with other health ingredients, such as probiotics, positions it for exponential growth in nutraceutical and clinical nutrition sectors.
During the forecast period, the North America region is expected to hold the largest market share due to high health awareness, strong R&D investments, and a well-established nutraceutical industry. The U.S. dominates with a dense network of dairy farms and regulatory support for colostrum-based products. Rising demand for immune-boosting supplements and sports nutrition, coupled with premiumization trends, sustains market growth. Strategic collaborations between manufacturers and healthcare providers further reinforce regional dominance.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by expanding middle-class populations, urbanization, and increasing disposable incomes. Countries like China and India witness surging demand for pediatric nutrition and functional foods. Government initiatives promoting maternal and child health, alongside rising awareness of colostrum's benefits, drive adoption. Additionally, e-commerce expansion and entry of global brands into untapped markets position the region for rapid growth, supported by a shift toward preventive healthcare post-pandemic.
Key players in the market
Some of the key players in Colostrum Market include NOW Foods, Cure Nutraceutical Pvt. Ltd., The Saskatoon Colostrum Company Ltd., Good Health Products Ltd, Sterling Technology, Deep Blue Health New Zealand Ltd., PanTheryx Inc., Biostrum Nutritech Pvt. Ltd., Colostrum BioTec GmbH, Biotaris B.V., Ingredia Nutritional, APS Biogroup Inc., La Belle Inc., Fonterra Co-operative Group Ltd., NIG Nutritionals Limited, Titan Biotech Ltd., Biodane Pharma A/S and Glanbia PLC.
In August 2024, NOW(R), a family-owned brand that has been empowering the healthy living community for more than 55 years, makes significant and unique additions to its vast wellness portfolio with the launch of its Omega-3 Gummy Chews supplement and E-Sport Reaction gaming performance supplement, which are available online and at select natural retailers nationwide.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.